financetom
Business
financetom
/
Business
/
Emerson Electric To Buy Out AspenTech Minority Stake In $7.2 Billion Cash Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Emerson Electric To Buy Out AspenTech Minority Stake In $7.2 Billion Cash Deal
Jan 27, 2025 5:43 AM

Aspen Technology, Inc. ( AZPN ) shares are trading higher premarket on Monday after the company inked a deal to be acquired by Emerson Electric Company ( EMR ) in an all-cash tender offer for $265 per share.

Emerson will make a tender offer to acquire all outstanding shares of AspenTech that it does not own, valuing the minority stake at $7.2 billion and valuing the total company at a fully diluted market capitalization of $17.0 billion with an enterprise value of $16.8 billion.

Emerson currently owns 57% of AspenTech’s shares following its 55% majority investment in 2022.

This will followed by a merger in which any untendered shares will also be converted into the right to receive $265.00 per share in cash.

The offer is contingent upon at least a majority of AspenTech’s common shares held by minority shareholders being tendered.

The transaction is expected to close in the first half of 2025, subject to customary closing conditions.

Emerson plans to finance the deal through a combination of cash on hand and debt. Post closure, AspenTech’s common stock will be delisted from NASDAQ. Upon completion, AspenTech will become a wholly owned subsidiary of Emerson.

The transaction has been unanimously recommended for approval by a special committee of AspenTech’s Board of Directors formed to evaluate Emerson’s non-binding proposal made on November 5, 2024.

Notably, in November, Emerson proposed acquiring all remaining shares of Aspen Technology ( AZPN ), which implied a fully diluted market capitalization of $15.3 billion and an Enterprise Value of $15.1 billion.

That time, Emerson’s proposal of $240 per share offered a 35% premium over AspenTech’s undisturbed share price of $177.84 on August 6, and an 8% premium above its 52-week high of $221.94 through August 6.

Emerson held cash and equivalents of $8.05 billion as of September.

Aspen plans to release second quarter FY25 results on Tuesday, February 4, 2025.

Investors can gain exposure to AspenTech via ProShares S&P Kensho Smart Factories ETF ( MAKX ) and FM Focus Equity ETF ( FMCX ) .

Price Action: AZPN shares are up 3.07 % at $262.99 premarket at the last check Monday.

Read Next:

BHP’s CEO Sees No ‘Must Do’ Transactions, Abandons Anglo American For Now

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved